ExactAntigen

SUMO1 antibody | antibody review based on formal publications
SUMO1 antibodies
This is a review about SUMO1 antibodies, based on 19 published articles using SUMO1 antibodies in western blot, immunohistochemistry, immunoprecipitation, immunocytochemistry, and other immunological technologies. It is aimed to help ExactAntigen visitors find the most suited SUMO1 antibody.
Sigma-Aldrich    search Sigma-Aldrich SUMO1 products
chip, ip, wbSigma Daxx antibody was used in western blot, immunoprecipitation, and ChIP assay to study transcriptional repression of smad4. to the paper
Santa Cruz Biotechnology    search Santa Cruz Biotechnology SUMO1 products
ihSanta Cruz Biotechnology small ubiquitin modifier-1 (SUMO-1) antibody was used in immunohistochemistry (1 : 100) to study TDP-43 pathology in familial frontotemporal dementia and motor neuron disease without Progranulin mutations. to the paper
ip, wbSanta Cruz Biotechnology anti-SUMO antibody was used in western blot and immunoprecipitation to study tumor necrosis factor alpha-induced desumoylation and cytoplasmic translocation of homeodomain-interacting protein kinase 1. to the paper
wbSanta Cruz SUMO-1 (D-11) antibody was used in western blot to study transcriptional repression of smad4. to the paper
wbSanta Cruz Biotechnology mouse monoclonal antibody for SUMO-1 was used in western blot to provide the first evidence that SUMO modifications can directly affect the activity of the human TFIID complex. to the paper
wbSanta Cruz anti-Sumo-1 (FL-101) antibody was used in western blot to study PIAS-1 roles during cell cycle progression. to the paper
icSanta Cruz rabbit anti-SUMO-1 antibody was used in immunocytochemistry to indentify a nuclear export signal and the protein interaction domains in deformed epidermal autoregulatory factor-1 (DEAF-1). to the paper
MBL International    search MBL International SUMO1 products
wbMedical and Biological Laboratories anti-SUMO-1 antibody was used in western blot to investigate the interaction between SUMO-1 and Smad3 in human embryonic kidney carcinoma cell line, 293T cells. to the paper
Invitrogen    search Invitrogen SUMO1 products
wbZymed Laboratories anti-SUMO1 antibody was used in western blot to detect SUMO1 in HEK293 cells co-transfected with His-SUMO isoforms (SUMO1, SUMO2, and SUMO3) and full-length human tau or alpha-synuclein. to the paper
wbZymed Laboratories anti-SUMO antibody was used in western blot to study the regulation of MEF2 by histone deacetylase 4 and SIRT1 deacetylase-mediated lysine modifications. to the paper
wbZymed Laboratories mouse anti-GMP1 antibody was used in western blot to study the role of MMS21/NSE2 in DNA repair. to the paper
ic, ipZymed Laboratories anti-SUMO-1 antibody was used in immunoprecipitation and immunocytochemistry to demonstrate that SUMOylation of the Ataxin-1 is dependent on a functional nuclear localization signal. to the paper
wbZymed Laboratories SUMO-1 (GMP-1) antibody was used in western blot to study transcriptional repression of smad4. to the paper
ihZymed Laboratories SUMO-1 antibody was used in immunohistochemistry to demonstrate that the sumoylation of NFAT1 defines a novel mechanism of the nuclear anchorage and transcriptional activation downstream. to the paper
wbZymed Laboratories mouse monoclonal anti-SUMO-1 was used in western blot to detect SUMO-1 in COS-1 cells. to the paper
icZymed monoclonal anti-SUMO-1 antibody was used in immunocytochemistry to study the role of Siah1a in meiosis I completion in male mice. to the paper
wbZymed Laboratories Inc. monoclonal anti-SUMO1 antibody was used in mouse 3T3-L1 fibroblasts, 3T3-L1 adipocytes and in western blot to study the interaction between GLUT4 and Daxx. to the paper
icZymed Labs anti–GMP1 antibody was used in immunocytochemistry to study the function of CENP-A phosphorylation in completion of cytokinesis. to the paper
icZymed Laboratories mouse monoclonal anti-SUMO-1 (21C7) antibody was used in immunocytochemistry to characterize the interaction between RanBP2 and Ubc9. to the paper
wbZymed anti-SUMO-1 antibody was used in western blotting to investigate sumoylation of tumor suppressor p53 by PIAS1. to the paper
ALEXIS
icAlexis rabbit polyclonal SUMO-1/Sentrin-1 antibody was used in immunocytochemistry to characterize the interaction between RanBP2 and Ubc9. to the paper
LAE BIOTECH
wbLAE Biotech anti-SUMO1 antibody was used in human HeLa cells and in western blot to study the molecular mechanism of SUMO1 conjugation to TOP1. to the paper
Articles Reviewed
1:Harro Seelaar et al. TDP-43 pathology in familial frontotemporal dementia and motor neuron disease without Progranulin mutations. 2007
2:Véronique Dorval et al. Small ubiquitin-like modifier (SUMO) modification of natively unfolded proteins tau and alpha-synuclein. 2006
3:Meiluen Yang et al. Assembly of a polymeric chain of SUMO1 on human topoisomerase I in vitro. 2006
4:Patrick Ryan Potts et al. Human MMS21/NSE2 is a SUMO ligase required for DNA repair. 2005
5:Michaël Boyer-Guittaut et al. SUMO-1 modification of human transcription factor (TF) IID complex subunits: inhibition of TFIID promoter-binding activity through SUMO-1 modification of hsTAF5. 2005
6:Brigit E Riley et al. SUMOylation of the polyglutamine repeat protein, ataxin-1, is dependent on a functional nuclear localization signal. 2005
7:Xuan Zhao et al. Regulation of MEF2 by histone deacetylase 4- and SIRT1 deacetylase-mediated lysine modifications. 2005
8:Xianghong Li et al. Tumor necrosis factor alpha-induced desumoylation and cytoplasmic translocation of homeodomain-interacting protein kinase 1 are critical for apoptosis signal-regulating kinase 1-JNK/p38 activation. 2005
9:Che-Chang Chang et al. Daxx mediates the small ubiquitin-like modifier-dependent transcriptional repression of Smad4. 2005
10:Philip J Jensik et al. Identification of a nuclear export signal and protein interaction domains in deformed epidermal autoregulatory factor-1 (DEAF-1). 2004
11:Yasuhito Terui et al. Dual role of sumoylation in the nuclear localization and transcriptional activation of NFAT1. 2004
12:Eliana Munarriz et al. PIAS-1 is a checkpoint regulator which affects exit from G1 and G2 by sumoylation of p73. 2004
13:Seiyu Imoto et al. Regulation of transforming growth factor-beta signaling by protein inhibitor of activated STAT, PIASy through Smad3. 2003
14:Hisato Saitoh et al. Perturbation of SUMOlation enzyme Ubc9 by distinct domain within nucleoporin RanBP2/Nup358. 2002
15:Ross A Dickins et al. The ubiquitin ligase component Siah1a is required for completion of meiosis I in male mice. 2002
16:Sha Tian et al. Small ubiquitin-related modifier-1 (SUMO-1) modification of the glucocorticoid receptor. 2002
17:Vassiliki S Lalioti et al. The insulin-sensitive glucose transporter, GLUT4, interacts physically with Daxx. Two proteins with capacity to bind Ubc9 and conjugated to SUMO1. 2002
18:T Kahyo et al. Involvement of PIAS1 in the sumoylation of tumor suppressor p53. 2001
19:S G Zeitlin et al. CENP-A is phosphorylated by Aurora B kinase and plays an unexpected role in completion of cytokinesis. 2001


2008©ExactAntigen home | browse | about